The Chemours Company (NYSE:CC) Plans $0.09 Quarterly Dividend

The Chemours Company (NYSE:CCGet Free Report) declared a quarterly dividend on Tuesday, August 4th. Stockholders of record on Friday, August 14th will be paid a dividend of 0.0875 per share by the specialty chemicals company on Tuesday, September 15th. This represents a c) dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date is Friday, August 14th.

Chemours has decreased its dividend by an average of 0.1%annually over the last three years. Chemours has a dividend payout ratio of 14.5% meaning its dividend is sufficiently covered by earnings. Research analysts expect Chemours to earn $2.24 per share next year, which means the company should continue to be able to cover its $0.35 annual dividend with an expected future payout ratio of 15.6%.

Chemours Stock Up 4.9%

Shares of Chemours stock opened at $17.94 on Wednesday. Chemours has a 12-month low of $10.44 and a 12-month high of $28.67. The company has a quick ratio of 0.87, a current ratio of 1.82 and a debt-to-equity ratio of 18.98. The stock has a 50 day moving average price of $19.67 and a two-hundred day moving average price of $20.06. The stock has a market capitalization of $2.70 billion, a P/E ratio of -6.80 and a beta of 1.43.

Chemours (NYSE:CCGet Free Report) last released its earnings results on Tuesday, August 4th. The specialty chemicals company reported $0.42 earnings per share for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.08). Chemours had a positive return on equity of 52.49% and a negative net margin of 6.82%.The firm had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.65 billion. During the same period in the prior year, the firm earned ($2.54) EPS. The firm’s revenue was down 1.5% on a year-over-year basis. Equities analysts expect that Chemours will post 1.18 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on CC shares. Zacks Research raised Chemours from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, July 21st. Weiss Ratings reiterated a “sell (d)” rating on shares of Chemours in a research report on Friday, July 17th. Royal Bank Of Canada increased their price target on shares of Chemours from $26.00 to $29.00 and gave the stock an “outperform” rating in a research report on Monday, May 11th. Mizuho cut their price target on shares of Chemours from $30.00 to $25.00 and set an “outperform” rating for the company in a research note on Wednesday, July 1st. Finally, Truist Financial increased their target price on Chemours from $27.00 to $30.00 and gave the stock a “buy” rating in a report on Tuesday, April 28th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $24.10.

View Our Latest Report on CC

Chemours Company Profile

(Get Free Report)

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.

Featured Articles

Dividend History for Chemours (NYSE:CC)

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.